Interacting Drugs |
Metaproterenol vs Beta-Blockers (Beta1 Selective) |
Security Level |
 |
Mechanism |
Beta-Blockers (Beta1 Selective): May diminish the bronchodilatory effect of Beta2-Agonists. Of particular concern with nonselective beta-blockers or higher doses of the beta1 selective beta-blockers. |
Management |
Monitor therapy |
Metaproterenol vs Beta-Blockers (Beta1 Selective)
Post Review about Metaproterenol vs Beta-Blockers (Beta1 Selective) Click here to cancel reply.
Other Interactions of Metaproterenol
Other Interactions of Beta-Blockers (Beta1 Selective)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.